Overcoming oncolytic virus therapy production challenges through collaboration ByReciBioPharmMarch 13th 2024Discover how ReciBioPharm’s strategic approach helped to support the rapid delivery of an innovative oncolytic adenovirus therapy for advanced cancer to clinic.